Varicella post-exposure management for pediatric oncology patients.
暂无分享,去创建一个
D. Orbach | T. Hanslik | B. Pellegrino | B. Mesplès | M. Belloy | M. Tabone | B. Brethon | S. Cohen-Gogo | Juliette Saulpic | S. Raimbault | S. Nathanson | G. Raimondo | P. Trioche | C. Guillaumat | Hélène Sarda-Thibault | G. Costa | Solesne Papillard | Hani Jaber | Céline Gilet
[1] R. Chemaly,et al. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program , 2021, BMC Infectious Diseases.
[2] A. Fischer,et al. Different Clinical Presentations and Outcomes of Disseminated Varicella in Children With Primary and Acquired Immunodeficiencies , 2020, Frontiers in Immunology.
[3] J. Bate,et al. Up to a Quarter of Children With Cancer Develop Breakthrough Clinical Varicella Despite Receiving Post-exposure Prophylaxis With Varicella Immunoglobulin: A Single Centre UK Experience Over 3 Years. , 2020, Journal of pediatric hematology/oncology.
[4] J. Bate,et al. Successful Prevention of Varicella Outbreak With Oral Aciclovir Following Party for Pediatric Oncology Patients. , 2018, Journal of pediatric hematology/oncology.
[5] M. Jit,et al. PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer , 2018, Archives of Disease in Childhood.
[6] E. Yang,et al. Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis , 2016, Current Clinical Microbiology Reports.
[7] R. Bologna,et al. Varicella at "Casa Garrahan", 2008-2013: Assessment of postexposure prophylaxis measures. , 2015, Archivos argentinos de pediatria.
[8] N. Verma,et al. Successful prevention of varicella outbreak in an overcrowded paediatric oncology ward using oral acyclovir prophylaxis. , 2015, Journal of tropical pediatrics.
[9] A. Vora,et al. Postexposure chickenpox prophylaxis in children with leukaemia: a reply to the recent PEPtalk study and report of a service evaluation in a tertiary paediatric haematology centre in the UK , 2012, Archives of Disease in Childhood.
[10] C. Pui,et al. The controversy of varicella vaccination in children with acute lymphoblastic leukemia , 2012, Pediatric blood & cancer.
[11] P. Kearns,et al. PEPtalk: postexposure prophylaxis against varicella in children with cancer , 2011, Archives of Disease in Childhood.
[12] J. Bate,et al. Preventing varicella in children with malignancies: what is the evidence? , 2011, Current opinion in infectious diseases.
[13] M. Shinjoh,et al. Varicella zoster exposure on paediatric wards between 2000 and 2007: safe and effective post-exposure prophylaxis with oral aciclovir. , 2009, The Journal of hospital infection.
[14] U. Heininger,et al. Varicella , 2006, The Lancet.
[15] H. Ning,et al. Oral acyclovir prophylaxis of varicella after intimate contact. , 1997, The Pediatric infectious disease journal.
[16] K. Kida,et al. Postexposure prophylaxis of varicella in children with leukemia by oral acyclovir. , 1996, Pediatrics.
[17] J. Imanishi,et al. Postexposure prophylaxis of varicella in family contact by oral acyclovir. , 1993, Pediatrics.
[18] S. Feldman,et al. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. , 1987, Pediatrics.
[19] W. Hughes,et al. Varicella in children with cancer: Seventy-seven cases. , 1975, Pediatrics.
[20] A. Veerman,et al. Varicella outbreak in a pediatric oncology ward: the Manado experience. , 2010, Asian Pacific journal of cancer prevention : APJCP.